Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: A Food-Effect Study of CX11 in Healthy Participants [Phase 1]

View source ↗

Summary

CX11 is being studied in a Phase 1 food-effect trial in healthy participants. The study targets obesity and Type 2 Diabetes Mellitus and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CX11 (CX11)

Snippet

Sponsor: Vincentage Pharma Co., Ltd | Conditions: Obesity & Overweight, Type 2 Diabetes | Phase 1 | Status: RECRUITING